3 completed, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
Follow Dialysis: new trials by email Literature Review of Dialysis trials Research Report on Dialysis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics of Zoledronic Acid in Patients on Dialysis Zoledronic Acid Injection, 5.0 mg, single dose, Zoledronic Acid Injection, 2.5 mg, single dose - Chronic Kidney Disease, Osteoporosis | Phase 1 | Not yet recruiting | University of Campinas, Brazil | 24 | 2026-08-15 | 2026-09-10 |
| The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol Tetrahydrocannabinol-Cannabidiol Combination - Cannabis, Chronic Kidney Diseases | Phase 1 | Active not recruiting | McMaster University | 24 | 2024-01-11 | 2024-11-20 |
| Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD Empagliflozin, Placebo - End-stage Kidney Disease, Kidney Disease, Chronic | Phase 1 | Completed | University of Utah | 62 | 2023-03-21 | 2026-10-30 |
| Safety and TDM of Continuous Infusion Vancomycin Through Continuous Renal Replacement Therapy Solution Vancomycin - Pediatric Continuous Renal Replacement Therapy, Dialysis | Phase 1 | Unknown | Drexel University | 10 | 2017-01-01 | 2020-10-19 |
| An Evaluation of a Cytomegalovirus (CMV) Vaccine (ASP0113) in CMV-Seropositive and CMV-Seronegative Healthy Subjects and CMV-Seronegative Dialysis Patients ASP0113, Placebo - Dialysis, Healthy Subjects | Phase 1 | Completed | Astellas Pharma Global Development, Inc. | 48 | 2013-12-30 | 2024-10-17 |
| Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis N-acetylcysteine, placebo - End-Stage Renal Disease, Dialysis | Phase 1 | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 30 | 2007-03-01 | 2010-03-03 |
Renal Insufficiency, Chronic (3) · Kidney Failure, Chronic (2) · Renal Insufficiency (2) · Cytomegalovirus Infections (1) · Marijuana Abuse (1) · Osteoporosis (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Chronic Disease (4) · Disease Attributes (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Renal Insufficiency (3) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Chemically-Induced Disorders (1) · DNA Virus Infections (1)
Acetylcysteine (1) · Vancomycin (1) · Zoledronic Acid (1) · empagliflozin (1) · nabiximols (1)
Astellas Pharma Global Development, Inc. (1) · Drexel University (1) · McMaster University (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1) · University of Campinas, Brazil (1) · University of Utah (1)
United States (4) · Brazil (1) · Canada (1)
Jeffrey J Cies, PharmD, MPH (1) · Kirsten L Johansen, MD (1) · Michael Walsh, MD, PhD (1) · Rodrigo B de Oliveira, PhD (1)
R01DK131265 (1), R21DK077350 (1)